The efficiency and safety of low-dose intravenous indomethacin for closure of patent ductus arteriosus in preterm neonate: a randomized controlled trial

Abstract Patent ductus arteriosus (PDA) is a common complication in prematurity. Intravenous indomethacin, three doses, is an effective medication for closure PDA, but complications about renal impairment and gastrointestinal (GI) problems should be considered. This study aimed to compare the effica...

Полное описание

Библиографические подробности

Главные авторы:	Wasana Hongkan, Narueporn Petarwut, Thanatda Siriporn, Nirucha Thamwiriyakul, Tharathorn Durongbhandhu
Формат:	Artigo
Язык:	Inglês
Опубликовано:	Nature Portfolio 2025-11-01
Серии:	Scientific Reports
Предметы:	Patent ductus arteriosus Prematurity Intravenous indomethacin Closure PDA Low-dose indomethacin Complication of indomethacin
Online-ссылка:	https://doi.org/10.1038/s41598-025-23285-4
Метки:	Добавить метку Нет меток, Требуется 1-ая метка записи!